Thomas Johnson, Kumar Salini C
Department of Endocrinology, Diabetes & Metabolism, Nassau University Medical Center, East Meadow, NY 11554, USA.
Case Rep Endocrinol. 2013;2013:308086. doi: 10.1155/2013/308086. Epub 2013 Oct 1.
Nonislet cell tumor hypoglycemia (NICTH) is a rare cause of hypoglycemia. It is characterized by increased glucose utilization by tissues mediated by a tumor resulting in hypoglycemia. NICTH is usually seen in large mesenchymal tumors including tumors involving the GI tract. Here we will discuss a case, its pathophysiology, and recent advances in the management of NICTH. Our patient was diagnosed with poorly differentiated squamous cell carcinoma of esophagus. He continued to be hypoglycemic even after starting continuous tube feeds and D5W. General workup for hypoglycemia was negative and insulin-like growth factor II (IGF II) was in the normal range. Hypoglycemia secondary to "big" IGF II was considered, and patient was started on steroids. His hypoglycemia resolved within a day of treatment with steroids. Initially patient had hypoglycemia unawareness, which he regained after maintaining euglycemia for 48 hours.
非胰岛细胞瘤性低血糖症(NICTH)是一种罕见的低血糖病因。其特征是肿瘤介导组织对葡萄糖的利用增加,从而导致低血糖。NICTH通常见于大型间叶组织肿瘤,包括累及胃肠道的肿瘤。在此,我们将讨论一个病例、其病理生理学以及NICTH治疗方面的最新进展。我们的患者被诊断为食管低分化鳞状细胞癌。即使开始持续鼻饲和输注5%葡萄糖注射液后,他仍持续低血糖。低血糖的常规检查结果为阴性,胰岛素样生长因子II(IGF II)在正常范围内。考虑到低血糖继发于“大”IGF II,遂让患者开始使用类固醇治疗。使用类固醇治疗一天内,他的低血糖症状得到缓解。起初患者存在低血糖无意识现象,在血糖维持正常48小时后这种现象消失。